ProfileGDS4718 / 207317_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 57% 63% 98% 62% 64% 51% 50% 60% 68% 54% 62% 59% 57% 53% 54% 75% 63% 55% 50% 53% 66% 67% 63% 58% 60% 51% 69% 52% 57% 59% 57% 87% 62% 58% 72% 51% 54% 61% 61% 98% 57% 54% 79% 57% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.9345557
GSM549102patient 115, normal, homogenized [OPG study]6.3329563
GSM549104patient 119, normal, homogenized [OPG study]11.206698
GSM549108patient 138, normal, homogenized [OPG study]6.2994262
GSM549119patient 077, normal, homogenized [OPG study]6.3821264
GSM549133patient 032, cancer, homogenized [OPG study]5.5296951
GSM549139patient 042, cancer, homogenized [OPG study]5.4801350
GSM549099patient 107, normal, homogenized [OPG study]6.1175660
GSM549109patient 139, normal, homogenized [OPG study]6.7044868
GSM549110patient 046, normal, homogenized [OPG study]5.733954
GSM549114patient 063, normal, homogenized [OPG study]6.1968562
GSM549122patient 082, normal, homogenized [OPG study]6.0814759
GSM549134patient 033, cancer, homogenized [OPG study]5.8831657
GSM549136patient 036, cancer, homogenized [OPG study]5.6705553
GSM549140patient 044, cancer, homogenized [OPG study]5.7085954
GSM549111patient 047, normal, homogenized [OPG study]7.3648775
GSM549113patient 057, normal, homogenized [OPG study]6.3381863
GSM549132patient 031, cancer, homogenized [OPG study]5.8170455
GSM549137patient 038, cancer, homogenized [OPG study]5.5111250
GSM549142patient 047, cancer, homogenized [OPG study]5.798653
GSM549100patient 110, normal, homogenized [OPG study]6.4928566
GSM549107patient 135, normal, homogenized [OPG study]6.6259567
GSM549115patient 068, normal, homogenized [OPG study]6.3501463
GSM549116patient 072, normal, homogenized [OPG study]6.0132858
GSM549120patient 078, normal, homogenized [OPG study]6.1132560
GSM549131patient 030, cancer, homogenized [OPG study]5.5454251
GSM549118patient 074, normal, homogenized [OPG study]6.8196169
GSM549129patient 027, cancer, homogenized [OPG study]5.6295752
GSM549123patient 088, normal, homogenized [OPG study]5.9073757
GSM549124patient 006, cancer, homogenized [OPG study]6.0484759
GSM549126patient 015, cancer, homogenized [OPG study]5.9162657
GSM549128patient 025, cancer, homogenized [OPG study]8.7201387
GSM549103patient 117, normal, homogenized [OPG study]6.2640862
GSM549117patient 073, normal, homogenized [OPG study]5.9280158
GSM549138patient 041, cancer, homogenized [OPG study]7.1222472
GSM549141patient 045, cancer, homogenized [OPG study]5.5550151
GSM549130patient 028, cancer, homogenized [OPG study]5.7172854
GSM549101patient 111, normal, homogenized [OPG study]6.2225961
GSM549105patient 128, normal, homogenized [OPG study]6.1941461
GSM549106patient 134, normal, homogenized [OPG study]11.532798
GSM549112patient 048, normal, homogenized [OPG study]5.9330957
GSM549125patient 011, cancer, homogenized [OPG study]5.7495554
GSM549127patient 024, cancer, homogenized [OPG study]7.7873679
GSM549135patient 035, cancer, homogenized [OPG study]5.9336257